Skip to content

Clinical trials

Completed Observational Amyotrophic Lateral Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Observational Status: Completed Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20065
20078
20085
20093
20115
20123
20138
20145
201510
20166
20178
20185
20195
20206
20216
20225
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed109

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital7
National Institute of Neurological Disorders and Stroke (NINDS)6
Drexel University College of Medicine5
Peking University Third Hospital4
Beth Israel Deaconess Medical Center3
National Institute of Environmental Health Sciences (NIEHS)3
Wake Forest University Health Sciences3
Columbia University2
Duke University2
Haukeland University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis109
Motor Neuron Disease29
Neurodegenerative Diseases9
Muscular Atrophy, Spinal7
Movement Disorders6
Multiple Sclerosis6
Parkinson Disease6
Alzheimer Disease5
Cognitive Dysfunction5
Frontotemporal Dementia5

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.